|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Apellis Pharmaceuticals (NASDAQ: APLS) through any online brokerage.
The latest price target for Apellis Pharmaceuticals (NASDAQ: APLS) was reported by BMO Capital on July 8, 2021. The analyst firm set a price target for 89.00 expecting APLS to rise to within 12 months (a possible 30.67% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $68.11 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Apellis Pharmaceuticals.
There is no upcoming split for Apellis Pharmaceuticals.
Apellis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.